Tue, Sep 16, 2014, 7:38 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • drdoctor111 drdoctor111 Sep 11, 2013 1:53 PM Flag

    I bought more at 6.18.. here is why..

    It take 3.5% week over week sales to be profitable in 1 year for Belviq ,,see my other post with math)
    Profits from last ¼ = 41 million
    average expense run 24 million per ¼(over past year)
    In conference call they where in in talks..We get other deal like Taiwan.. maybe China… deals on either of our Phase 2 drugs…. ADP811 Temanogrel

    average expense will drop 2million dollar per ¼ …(Ildong is paying phase 2 A Temanogrel going on now..,Belviq cost will go down for supporting launch will go down.Partner doing next bel-phen testing)
    payment’s on this ¼
    900k get booked every ¼ from former milestone payment,,, so every ¼ we have 900K
    2 milion from Taiwan deal…
    +5 million ….. we have 3 more 500,000 milestones for other countries too plus Canada Brazil and Mexico = 1 million within 6 months
    +3 million Belviq milestone when approved in South Korea within 6 months,, (FYI Ildong pays up 45% to Arena for sales)
    +2 million…… We should be getting our 1st milestone payment from Ildong for Temanogrel… with-in the year (FYI good results from phase 1 testing,,u can read and research if wanted..)
    Unknow milestone for Taiwan 1 million to 500k is my guess,,,
    1 million in income from Siegfried AG drug over the next 4 ¼’s …. (also Siegfried AG drug sales increased by 12% not sure what drugs we produce for them but we could see increased sales numbers for them)
    1 million misc income ( (interest on investment,,,, grants for research govt and private .. )

    Add sales for Belviq… USA (100 million = 31 million in profits over next 3 ¼’s)
    Add Global sales for Belviq.. dependent on when countries come on line, (conservative 30 million = 6 million in profits…over next 4 ¼’s )

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.92+0.01(+0.26%)Sep 16 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.